Health News

Stay informed with the latest health industry news from around the globe. Read about advancements in health technology, updates in health insurance, innovations in medical devices, and more. Keep up with important health trends and industry developments.

May 8, 2026 at 6:40 PM

Encompass Health Acquires 7 Acres in Haslet for New Inpatient Rehabilitation Hospital

HASLET, Texas--(BUSINESS WIRE)--Davidson Bogel Real Estate (DB2RE) is pleased to announce the sale of approximately 7 acres of land located at the southwest corner of Haslet Parkway and Harmon Road in Haslet, Texas. Collins Meier, Ryan Turner, David Davidson, Jr., and Edward Bogel represented the seller in the transaction. The buyer, Encompass Health, partnered closely with the land owner and master developer, Terra Manna, to bring the project to fruition. JLL represented the buyer in the trans...
May 8, 2026 at 5:00 PM

SINOVAC Reports Unaudited First Half of 2025 Financial Results

BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended June 30, 2025. First Half of 2025 Financial Summary Sales for the six months ended June 30, 2025 were $130.3 million, compared to $128.7 million in the prior year period. The Company posted $21.7 million of net loss attributable to common shareholders, or a loss of $0.30 per...
May 8, 2026 at 4:31 PM

Coolibar and Skin Cancer Survivor and Advocate, Dayanara Torres, Redefine Life in the Sun for Skin Cancer Awareness Month

MIAMI--(BUSINESS WIRE)--Coolibar, the world’s leading UPF 50+ sun protection apparel brand, is continuing its partnership with skin cancer survivor and advocate Dayanara Torres and the Melanoma Research Foundation (MRF) for Skin Cancer Awareness Month this May. The 2026 campaign brings a more intimate and elevated creative direction to Coolibar’s sun safety message, using emotional storytelling to encourage prevention, protection, and early detection. Together, the partners aim to reach communi...
May 8, 2026 at 4:30 PM

Kairos Pharma, Ltd. Sets Annual Meeting of Shareholder Date and Provides Update on Its Annual Filings

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, announces that its Annual Meeting of Shareholders will be held virtually at 9:00 am PDT on Monday, June 29, 2026. After the meeting materials are finalized and filed with the Securities and Exchanges Commission, such materials will be mailed to shareholders. The Company also advises its Financial Statements included in its Annual Report o...
May 8, 2026 at 4:30 PM

Ensoma to Present Clinical Safety Data from First Participant Dosed with In Vivo HSC Engineering Therapy at ASGCT Annual Meeting

BOSTON--(BUSINESS WIRE)--Ensoma, an in vivo cellular engineering company with a mission to advance the future of medicine through one-time therapies, today announced the presentation of initial clinical data from the first participant dosed in its Phase 1/2 trial of EN-374 for the treatment of X-linked chronic granulomatous disease (X-CGD) at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting, taking place May 11-15 in Boston. The data represent the first reported clini...
May 8, 2026 at 4:05 PM

TruBridge Announces First Quarter 2026 Results

MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG) (“TruBridge”), a leading provider of healthcare technology solutions for rural and community hospitals, today announced financial results for the first quarter ended March 31, 2026. Recent Developments As previously announced on April 23, 2026, TruBridge announced a definitive agreement whereby TruBridge, Inc. will be acquired by Inventurus Knowledge Solutions, Inc. (“IKS”), the U.S. subsidiary of Inventurus Knowledge Solutions Limit...
May 8, 2026 at 4:00 PM

Cryo-Cell Receives Acceptance of Compliance Plan From NYSE American

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that the NYSE American LLC (the “NYSE American") has accepted the Company’s previously submitted plan to regain compliance with continued listing standards. As previously disclosed on March 12, 2026, the Company was notified that it was not in compliance with Section 1003 (a) of the NYSE American Co...
May 8, 2026 at 3:22 PM

KBRA Assigns AA+ Rating to Harris County Hospital District (TX) Series 2026 Limited Tax and Refunding Bonds; Affirms Rating for Parity Bonds

NEW YORK--(BUSINESS WIRE)--KBRA assigns a long-term rating of AA+ to the Harris County Hospital District's, TX (the "District") Series 2026, Limited Tax and Refunding Bonds. Concurrently, KBRA affirms the long-term AA+ rating for outstanding limited tax bonds. The Rating Outlook is Stable. Key Credit Considerations The rating actions reflect the following key credit considerations: Credit Positives A growing tax base continues to generate strong property tax revenues for the District, thus supp...
May 8, 2026 at 11:30 AM

Saban Community Clinic Breaks Ground on Crenshaw Family Health Center, Expanding Access For Over 287,000 Low-Income People in One of Los Angeles’ Most Underserved Communities

LOS ANGELES--(BUSINESS WIRE)--Saban Community Clinic (SCC) today breaks ground on its new Crenshaw Family Health Center, a major expansion that will bring comprehensive, community-based healthcare to the heart of South Los Angeles, one of the most underserved regions in Los Angeles County. The new facility is located in the historic Crenshaw Corridor and will serve a community where more than 287,000 low-income residents face limited access to primary care. The project directly addresses longst...
May 8, 2026 at 11:18 AM

Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology

BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced that SkinCure Oncology and Sensus Healthcare have amicably resolved their dispute and are moving forward constructively with a shared commitment to patient care and clinical excellence. In March 2026, Sensus Healthcare filed a lawsuit in the Circuit Court for the Fifteenth Judicial Cir...
Turn Your News Into Headlines
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up